Latest filing published 10 Jul 2025 for LIFECORE BIOMEDICAL, INC. \DE\.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Paul Josephs on record concern Lifecore Biomedical, Inc. \DE\. We count 8 filings; the first trade dates from 20 May 2024 and the latest from 8 July 2025.
On the market, this insider has only ever bought: 1 purchase, €94k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 1 option exercise. 2025 to date brings 1 purchase and no sales.
Most recently, on 10 July 2025, the filings show a share grant worth €383k in Lifecore Biomedical, Inc. \DE\. The clock since the last published purchase (8 January 2025) now reads 654 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations